{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:52:46Z","timestamp":1790297566283,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese Academy of Sciences \u201c100 Talents\u201d program","award":["KSCX2-YW-BR-2"],"award-info":[{"award-number":["KSCX2-YW-BR-2"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.03.007","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T06:30:26Z","timestamp":1363156226000},"page":"2215-2221","source":"Crossref","is-referenced-by-count":63,"title":["Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection"],"prefix":"10.1016","volume":"31","author":[{"given":"Yicun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8 (August)","key":"10.1016\/j.vaccine.2013.03.007_bib0005","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2013.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00006454-199912000-00013","article-title":"Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998","volume":"18","author":"Chang","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2013.03.007_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/JCM.00718-06","article-title":"Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003","volume":"45","author":"Hosoya","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"4 (July)","key":"10.1016\/j.vaccine.2013.03.007_bib0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7883\/yoken.JJID.2009.254","article-title":"Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007","volume":"62","author":"Iwai","year":"2009","journal-title":"Jpn J Infect Dis"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2013.03.007_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"2 (November)","key":"10.1016\/j.vaccine.2013.03.007_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3181\/00379727-90-22088","article-title":"Recently classified types of Coxsackie virus, group A; behavior in tissue culture","volume":"90","author":"Sickles","year":"1955","journal-title":"Proc Soc Exp Biol Med"},{"issue":"6","key":"10.1016\/j.vaccine.2013.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00705-006-0934-5","article-title":"Molecular phylogeny of modern coxsackievirus A16","volume":"152","author":"Perera","year":"2007","journal-title":"Arch Virol"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2013.03.007_bib0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/JCM.02338-09","article-title":"Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China","volume":"48","author":"Zhang","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.03.007_bib0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1743-422X-8-534","article-title":"Construction and characterization of an infectious clone of coxsackievirus A16","volume":"8","author":"Liu","year":"2011","journal-title":"Virol J"},{"issue":"1 (April)","key":"10.1016\/j.vaccine.2013.03.007_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"issue":"8 (October)","key":"10.1016\/j.vaccine.2013.03.007_bib0055","first-page":"615","article-title":"Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus","volume":"79","author":"Robinson","year":"1958","journal-title":"Can Med Assoc J"},{"issue":"May","key":"10.1016\/j.vaccine.2013.03.007_bib0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","article-title":"Fatal infection in an infant associated with Coxsackie virus group A, type 16","volume":"268","author":"Wright","year":"1963","journal-title":"N Engl J Med"},{"issue":"May","key":"10.1016\/j.vaccine.2013.03.007_bib0065","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(63)80047-5","article-title":"Myocarditis possibly due to Coxsackie group A, type 16, virus","volume":"62","author":"Goldberg","year":"1963","journal-title":"J Pediatr"},{"issue":"3 (March)","key":"10.1016\/j.vaccine.2013.03.007_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"7 (July)","key":"10.1016\/j.vaccine.2013.03.007_bib0075","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3201\/eid1307.070295","article-title":"Fatal coxsackievirus A-16 pneumonitis in adult","volume":"13","author":"Legay","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"10 (October)","key":"10.1016\/j.vaccine.2013.03.007_bib0080","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1510.090594","article-title":"Rhombencephalitis and coxsackievirus A16","volume":"15","author":"Goto","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.03.007_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2013.03.007_bib0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1743-422X-8-508","article-title":"Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"issue":"4 (April)","key":"10.1016\/j.vaccine.2013.03.007_bib0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jcv.2009.02.002","article-title":"An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China","volume":"44","author":"Zhang","year":"2009","journal-title":"J Clin Virol"},{"issue":"4 (April)","key":"10.1016\/j.vaccine.2013.03.007_bib0100","first-page":"339","article-title":"Analysis on the epidemiological and genetic characteristics of enterovirus type 71 and Coxsackie A16 virus infection in Jiangsu, China","volume":"30","author":"Pan","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"5 (October)","key":"10.1016\/j.vaccine.2013.03.007_bib0105","first-page":"334","article-title":"To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008","volume":"23","author":"Zhang","year":"2009","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2013.03.007_bib0110","first-page":"3341","article-title":"Severe hand-foot-and-mouth disease caused by mixed infection of enterovirus 71 and coxsackie A16: reports of 6 cases","volume":"29","author":"Zhang","year":"2011","journal-title":"Chin Gen Pract"},{"issue":"9 (September)","key":"10.1016\/j.vaccine.2013.03.007_bib0115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00705-010-0722-0","article-title":"Emergence of enterovirus 71 double-recombinant\u201d strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71","volume":"155","author":"Yip","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2013.03.007_bib0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"issue":"20 (April)","key":"10.1016\/j.vaccine.2013.03.007_bib0125","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the Far East?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2013.03.007_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"22 (November)","key":"10.1016\/j.vaccine.2013.03.007_bib0135","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"issue":"47 (October)","key":"10.1016\/j.vaccine.2013.03.007_bib0140","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"3 (December)","key":"10.1016\/j.vaccine.2013.03.007_bib0145","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.antiviral.2008.06.017","article-title":"Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16","volume":"80","author":"Wu","year":"2008","journal-title":"Antiviral Res"},{"issue":"1\u20132 (December)","key":"10.1016\/j.vaccine.2013.03.007_bib0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus","volume":"186","author":"Ku","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2013.03.007_bib0155","first-page":"493","article-title":"A simple method of estimating 50 percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"Suppl. 4 (December)","key":"10.1016\/j.vaccine.2013.03.007_bib0160","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2011.10.005","article-title":"The global polio eradication initiative: lessons learned and prospects for success","volume":"29","author":"Aylward","year":"2011","journal-title":"Vaccine"},{"issue":"1 (March)","key":"10.1016\/j.vaccine.2013.03.007_bib0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-012-0237-z","article-title":"Progress on the research and development of human enterovirus 71 (EV71) vaccines","volume":"7","author":"Liang","year":"2013","journal-title":"Front Med"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2013.03.007_bib0170","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease","volume":"84","author":"Ong","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.03.007_bib0175","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2013.03.007_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2006.06.083","article-title":"High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture","volume":"25","author":"Liu","year":"2007","journal-title":"Vaccine"},{"issue":"8 (August)","key":"10.1016\/j.vaccine.2013.03.007_bib0185","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/JCM.43.8.3835-3839.2005","article-title":"Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China","volume":"43","author":"Li","year":"2005","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T06:40:33Z","timestamp":1688107233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":37,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13002661"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}